SCHEMBL3775765

SCHEMBL3775765

Cc1c(C(=O)N2CC(N3CCN(c4ccccn4)CC3)C2)oc2ccccc12

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.79
HTT P42858 2/20 0.79
HSD17B10 Q99714 2/20 0.79
TSHR P16473 3/20 0.59
LMNA P02545 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
MAPK1 P28482 1/20 0.59
RECQL P46063 2/20 0.55
HPGD P15428 1/20 0.53
KMT2A Q03164 5/20 0.52
MEN1 O00255 2/20 0.49
MAPT P10636 2/20 0.49
POLB P06746 1/20 0.49
GLA P06280 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
NPC1 O15118 1/20 0.48
MGLL Q99685 1/20 0.48
KDM4E B2RXH2 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3777600 0.79 ALDH1A1 (0.49) ALDH1A1HTTHSD17B10LMNASMN1; SMN2
SCHEMBL3771413 0.74 TSHR (0.53) ALDH1A1HTTHSD17B10TSHRSMN1; SMN2
SCHEMBL15703688 0.73 ALDH1A1 (0.55) ALDH1A1HSD17B10TSHRLMNASMN1; SMN2
SCHEMBL15703668 0.73 ALDH1A1 (0.76) ALDH1A1HSD17B10TSHRLMNASMN1; SMN2
SCHEMBL3770825 0.73 ALDH1A1 (0.61) ALDH1A1HSD17B10TSHRSMN1; SMN2MAPK1
SCHEMBL3772688 0.71 ALDH1A1 (0.56) ALDH1A1HSD17B10TSHRLMNASMN1; SMN2
SCHEMBL3776372 0.71 TSHR (0.79) ALDH1A1TSHRMAPK1RECQLKMT2A
SCHEMBL3776887 0.71 HSD17B10 (0.55) ALDH1A1HTTHSD17B10TSHRLMNA
SCHEMBL3780279 0.71 MGLL (0.57) ALDH1A1LMNAMAPK1HPGDKMT2A
SCHEMBL27090945 0.71 GPR119 (0.68) ALDH1A1HSD17B10TSHRLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421852-B9 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITOR JANSSEN PHARMACEUTICA NV (BE) 2015-07-01 EP disclosed
US-8815839-B2 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2014-08-26 US disclosed
EP-2421852-B1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITOR JANSSEN PHARMACEUTICA NV (BE) 2014-05-21 EP disclosed
US-20130184251-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA, NV (BE) 2013-07-18 US disclosed
US-8415341-B2 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2013-04-09 US disclosed
US-20100324015-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324015-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS MGLL, PNLIP, LIPC ALDH1A1 662/4885HTT 2718/4885HSD17B10 424/4885
US-20130184251-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS MGLL, PNLIP, LIPC ALDH1A1 662/4885HTT 2718/4885HSD17B10 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.